Dolphin Entertainment Inc. (DLPN): Price target $7

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	11
Posts	832
Boards Moderated	0
Alias Born	03/13/2019

CyrusDaVirus

Re: None

Thursday, 06/04/2020 7:55:57 AM

Thursday, June 04, 2020 7:55:57 AM

Price target $7

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent DLPN News

HedoniaUSA Inc. Selects Dolphin Entertainment As Its Communications Agency of Record • PR Newswire (US) • 12/21/2023 02:21:00 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/18/2023 09:32:08 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 07:12:54 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:31:01 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 05:10:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 09:44:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:05:41 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/01/2023 08:13:52 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/30/2023 08:40:46 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/10/2023 01:29:04 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/10/2023 01:27:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 08:13:45 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:00:48 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/04/2023 04:15:24 AM
Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 07/28/2023 05:59:56 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/26/2023 12:13:08 PM

More DLPN News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover